These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 15173076)

  • 1. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
    Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.
    Gross C; Hansch D; Gastpar R; Multhoff G
    Biol Chem; 2003 Feb; 384(2):267-79. PubMed ID: 12675520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
    Moser C; Schmidbauer C; Gürtler U; Gross C; Gehrmann M; Thonigs G; Pfister K; Multhoff G
    Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
    Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.
    Yang SC; Grimm EA; Parkinson DR; Carinhas J; Fry KD; Mendiguren-Rodriguez A; Licciardello J; Owen-Schaub LB; Hong WK; Roth JA
    Cancer Res; 1991 Jul; 51(14):3669-76. PubMed ID: 1648441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells.
    Gastpar R; Gross C; Rossbacher L; Ellwart J; Riegger J; Multhoff G
    J Immunol; 2004 Jan; 172(2):972-80. PubMed ID: 14707070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation.
    Gross C; Holler E; Stangl S; Dickinson A; Pockley AG; Asea AA; Mallappa N; Multhoff G
    Leuk Res; 2008 Apr; 32(4):527-34. PubMed ID: 17543383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
    Milani V; Stangl S; Issels R; Gehrmann M; Wagner B; Hube K; Mayr D; Hiddemann W; Molls M; Multhoff G
    J Transl Med; 2009 Jun; 7():50. PubMed ID: 19549307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
    Burns LJ; Weisdorf DJ; DeFor TE; Vesole DH; Repka TL; Blazar BR; Burger SR; Panoskaltsis-Mortari A; Keever-Taylor CA; Zhang MJ; Miller JS
    Bone Marrow Transplant; 2003 Jul; 32(2):177-86. PubMed ID: 12838283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleofection of non-B cells with mini-Epstein-Barr virus DNA.
    Radons J; Gross C; Stangl S; Multhoff G
    J Immunol Methods; 2005 Aug; 303(1-2):135-41. PubMed ID: 16055146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
    Soiffer RJ; Murray C; Shapiro C; Collins H; Chartier S; Lazo S; Ritz J
    Clin Cancer Res; 1996 Mar; 2(3):493-9. PubMed ID: 9816195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells.
    Gehrmann M; Marienhagen J; Eichholtz-Wirth H; Fritz E; Ellwart J; Jäättelä M; Zilch T; Multhoff G
    Cell Death Differ; 2005 Jan; 12(1):38-51. PubMed ID: 15592361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 14-mer peptide from HSP70 protein is the critical epitope which enhances NK activity against tumor cells in vivo.
    Zhang H; Liu R; Huang W
    Immunol Invest; 2007; 36(3):233-46. PubMed ID: 17558707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S; Ishikawa A; Ishikawa E; Otsuji M; Iizasa T; Hanaoka H; Shimizu N; Horiguchi S; Okamoto Y; Fujii S; Taniguchi M; Fujisawa T; Nakayama T
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6079-86. PubMed ID: 17028247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
    Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
    Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.
    Gross C; Schmidt-Wolf IG; Nagaraj S; Gastpar R; Ellwart J; Kunz-Schughart LA; Multhoff G
    Cell Stress Chaperones; 2003; 8(4):348-60. PubMed ID: 15115287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells.
    Hromadnikova I; Li S; Kotlabova K; Dickinson AM
    PLoS One; 2016; 11(3):e0151535. PubMed ID: 26982331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.